Back to Search
Start Over
Cost implications of random mandatory drugs tests in prisons.
- Source :
-
Lancet (London, England) [Lancet] 1996 Oct 26; Vol. 348 (9035), pp. 1124-7. - Publication Year :
- 1996
-
Abstract
- Background: Compulsory urine testing of prisoners for drugs, a control initiative, was introduced in eight prisons in England and Wales early in 1995. Despite no evidence of effectiveness, testing was extended to all prisons in England and Wales by March 1996. We consider the cost of testing.<br />Methods: We combined the costs of refusals, confirmatory tests, punishment of confirmed positives for cannabis or for class A drugs to estimate the average costs of random compulsory drugs testing. These costs were then compared to: i) the healthcare budget for a prison; and ii) the cost of putting in place a credible prisons' drugs reduction programme. We then used Scottish data on incarceration and regional prevalence of injecting drug users to estimate the extent of the injecting drug use problem that prisons face.<br />Findings: Costs per 28 days of the random mandatory drugs testing control initiative in an establishment for 500 inmates where refusal rate is a) 10% or b) nil; and 35% of urine samples test positive, one tenth of them for class A drugs were estimated at between a) 22,800 UK pounds and b) 16,000 UK pounds per 28 days [a) $US35,100 and b) $US24,600]. This cost was equivalent to twice the cost of running a credible drugs reduction and rehabilitation programme, and around half the total healthcare expenditure for a prison of 500 which averaged 41,114 UK pounds per 28 days [$US64,860]. Major cost-generating events were the punishment of refusals--over one third of cost a)--and testing positive for cannabis--over 50% of cost a). In Scotland, around 5% of injecting drug users (IDUs) are incarcerated at any time: 5% of Lothian's drugs care, treatment and prevention costs and 2.5% of its HIV/AIDS prevention budget in 1993-94 amounted to 101,300 UK pounds per annum--or 7770 UK pounds per 28 days ($US11,970)--and about 35% of monthly MDT costs.<br />Interpretation: We suggest that 5% of current resources for drugs prevention and treatment and for IDU-targetted HIV/AIDS prevention should be directed towards the prisons because in the prisons, where 5% of the clients are at any time, injectors have less access to harm reduction measures than on the outside.
- Subjects :
- Costs and Cost Analysis
Female
Gas Chromatography-Mass Spectrometry
Humans
Male
Prevalence
Punishment
Random Allocation
Substance-Related Disorders epidemiology
Substance-Related Disorders urine
United Kingdom epidemiology
Prisoners
Substance Abuse Detection economics
Substance-Related Disorders diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 0140-6736
- Volume :
- 348
- Issue :
- 9035
- Database :
- MEDLINE
- Journal :
- Lancet (London, England)
- Publication Type :
- Academic Journal
- Accession number :
- 8888165
- Full Text :
- https://doi.org/10.1016/S0140-6736(96)06318-0